Low-Dose Aspirin Continuation During Gastric Endoscopic Submucosal Dissection in Patients With Low Thrombotic Risk: A Randomized Trial
The noninferiority of LDA continuation over discontinuation for ESD-related major bleeding in gastric ESD was not demonstrated. Therefore, discontinuation of LDA during the periprocedural period is recommended for patients with low thrombotic risk (UMIN000013177).
Authors
- Noriya Uedo (ORCID: https://orcid.org/0000-0002-3029-9272)
- Koichi Kawabe
- Akihiro MATSUDA (ORCID: https://orcid.org/0009-0006-6884-0489)
- Shoichi Kayaba
- Takuji Akamatsu (ORCID: https://orcid.org/0000-0002-6826-9829)
- Yasuaki Nagami (ORCID: https://orcid.org/0000-0002-4617-2188)
- Takeshi Yamashina (ORCID: https://orcid.org/0000-0003-2845-7988)
- Kohei Takizawa (ORCID: https://orcid.org/0000-0002-7702-0427)
- Hisashi Doyama (ORCID: https://orcid.org/0000-0002-7457-0167)
- Kiyotaka Umeki
- Tetsu Arai
- Yoshimasa Miura
- Ichiro Oda
- Takuji Gotoda
- Toshiyuki Yoshio
- Satoshi Ono
- Hideki Ishikawa
- Yoshinobu Yamamoto
- Kenshi Matsumoto
- for the SET-UP Trial Group
- Osamu Dohi
Institutions
- Nihon University (JP)
- Jichi Medical University (JP)
- Osaka City University (JP)
- Juntendo University (JP)
- Kyoto Prefectural University of Medicine (JP)
- National Cancer Centre Japan (JP)
- Toyama Prefectural Central Hospital (JP)
- Shizuoka Cancer Center (JP)
- Iwate Prefectural Central Hospital (JP)
- Fukui Red Cross Hospital (JP)
- Chiba-Nishi General Hospital (JP)
- Ishikawa Prefectural Central Hospital (JP)
- Osaka International Cancer Institute (JP)
- Osaka Red Cross Hospital (JP)
- Japanese Red Cross Society Wakayama Medical Center (JP)
- Hyogo Prefectural Cancer Center (JP)
- Hirosaki University Hospital (JP)
- Japanese Foundation For Cancer Research (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.14309/ajg.0000000000003928
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00